Nanoscope Therapeutics to Present at Meeting on the Mesa 2026
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Integrated DNA, RNA and Whole-Blood Analysis Provides Deeper Molecular Insights for Precision OncologyIRVING, Texas, Sept. 29, 2026 /PRNewswire/ -- Caris...
American Lung Association launches campaign to educate people living with lung disease and other risk factors about critical vaccines CHICAGO,...
Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE:...
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and...
PALO ALTO, CA / ACCESS Newswire / September 29, 2026 / Bioz, Inc., a product validation platform that integrates peer-reviewed...
Proprietary intranasal delivery technology being developed initially for GLP-1 receptor agonistsLOUGHBOROUGH, United Kingdom, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Landmark...
– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models –...
Montreal, Quebec--(Newsfile Corp. - September 29, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"),...
Distribution partnership with one of Cyprus's most established healthcare and consumer-products distributorsHighlights:LOI with CPO Cyprus includes exclusive distribution of VIVI...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...